FDA medical oncologists discuss the first approval of a chimeric antigen receptor (CAR) T-cell immunotherapy.

FDA D.I.S.C.O.: First FDA approval of a CAR T-cell immunotherapy

FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.) is an FDA podcast series that provides information about new product approvals, emerging safety information for cancer treatments, and other current topics in cancer drug development.

Science

Share FDA D.I.S.C.O.: First FDA approval of a CAR T-cell immunotherapy

Sign up to save your podcasts

FDA D.I.S.C.O.: First FDA approval of a CAR T-cell immunotherapy

FDA D.I.S.C.O.: First FDA approval of a CAR T-cell immunotherapy